Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions
Clinical trial NCT07260851 · RECRUITING
Trial details
- NCT number
- NCT07260851
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2026-01-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.